Question 1

What is AB Science?

Accepted Answer

AB Science is a Company.

Question 2

How often does AB Science appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 13 articles.

Question 3

When was AB Science first tracked by Ergen?

Accepted Answer

First tracked on May 25, 2026.

Question 4

When was AB Science last mentioned in news?

Accepted Answer

Last active on Jun 02, 2026.

Question 5

What is AB Science's current news sentiment?

Accepted Answer

Aggregate sentiment score: 35 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is AB Science in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving AB Science?

Accepted Answer

Maxim_Group reiterates Buy on AB_Science (May 25, 2026, 6 articles).

Question 8

How did the "Maxim_Group reiterates Buy on AB_Science" event impact AB Science?

Accepted Answer

Maxim Group reiterated a Buy recommendation on AB Science>>>'s stock with a target price of €4.00 per share, following the release of its FYE2025 results and securing a clinical trial insurance policy. This positive coverage is expected to make financing for its Phase 3 ALS study more attractive.

Question 9

How did the "Stonegate Updates AB Science Coverage" event impact AB Science?

Accepted Answer

AB Science's stock coverage was updated by Stonegate Capital Partners, providing a valuation mid-point of EUR 4.25 per share, which could positively influence investor perception and stock performance. The company is advancing its clinical assets masitinib and AB8939.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.